Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®
February 09, 2022 07:23 ET
|
Lupin Ltd
Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla® Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic...